DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,624,000 | +17.2% | 13,504 | -1.7% | 2.42% | +9.2% |
| Q1 2021 | $3,092,000 | -1.7% | 13,739 | -2.9% | 2.21% | -3.3% |
| Q4 2020 | $3,144,000 | -2.8% | 14,155 | -5.8% | 2.29% | -13.5% |
| Q3 2020 | $3,234,000 | +17.6% | 15,020 | -3.5% | 2.65% | +7.2% |
| Q2 2020 | $2,751,000 | +24.5% | 15,560 | -2.5% | 2.47% | +11.1% |
| Q1 2020 | $2,209,000 | -10.6% | 15,960 | -0.8% | 2.22% | +18.0% |
| Q4 2019 | $2,470,000 | +5.2% | 16,091 | -1.1% | 1.88% | +1.7% |
| Q3 2019 | $2,349,000 | -0.3% | 16,266 | -1.3% | 1.85% | -0.4% |
| Q2 2019 | $2,356,000 | +5.8% | 16,486 | -2.2% | 1.86% | +4.6% |
| Q1 2019 | $2,226,000 | +23.6% | 16,861 | -3.4% | 1.78% | +8.6% |
| Q4 2018 | $1,801,000 | -5.8% | 17,461 | -0.7% | 1.64% | +7.2% |
| Q3 2018 | $1,911,000 | +10.1% | 17,586 | 0.0% | 1.53% | +1.9% |
| Q2 2018 | $1,735,000 | +4.6% | 17,586 | +3.8% | 1.50% | +3.4% |
| Q1 2018 | $1,658,000 | +10.3% | 16,936 | +4.6% | 1.45% | +17.1% |
| Q4 2017 | $1,503,000 | – | 16,194 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |